Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Additionally, American, ASCO, ASTRO, August, Bank, card, chronic, cisplatin, CKD, collateral, compelled, deal, deferral, deposit, doubt, driven, eGFR, exploration, guarantee, highlight, hoc, IMRT, kidney, meaningful, Oncology, opportunity, perception, post, predefined, prospective, realization, regimen, reinforced, renal, satisfaction, satisfactory, senior, showing, Society, spend, TD, thereon
Removed:
NaN
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view